International Journal of Medical and Pharmaceutical Research
2021, Volume-2, Issue-1
Original Article
Prevalence of Dry Eye Disease in Diabetic Patients Attending a Tertiary Care Teaching Hospital
Abstract

Background: Dry eye disease (DED) is a multifactorial disorder of the ocular surface characterized by tear film instability, ocular discomfort, and visual disturbance. Diabetes mellitus is known to affect various ocular structures and has been increasingly associated with dry eye disease due to neuropathy, microvascular damage, and altered tear secretion.

Objective: To determine the prevalence of dry eye disease among diabetic patients attending a tertiary care teaching hospital and to analyze its association with duration and control of diabetes.

Methods: A hospital‑based cross‑sectional study was conducted among adult diabetic patients attending the ophthalmology outpatient department. Detailed history taking, ocular examination, and dry eye evaluation using standard diagnostic tests were performed. Data were analyzed to determine prevalence and associated risk factors.

Results: Dry eye disease was observed in a significant proportion of diabetic patients. The prevalence increased with longer duration of diabetes and poor glycemic control. Mild to moderate dry eye was the most common presentation.

Conclusion: Dry eye disease is a common ocular complication among diabetic patients. Early screening and timely management are essential to improve ocular comfort and prevent vision‑related quality‑of‑life impairment

Recommended Articles
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-2, Issue-1
Citations
18 Views
0 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved